Biosenta, Livespace Homes enter field test deal

Executive Summary

• Biosenta Inc. has entered into a field test and research agreement with Livespace Homes to evaluate the real-world performance of its proprietary anti-microbial nanoparticle technology in a residential construction environment.
• The test involves incorporating the nanoparticles into building materials or coatings in two of the four units of a Livespace four-plex project in Alberta, allowing for a side-by-side comparison to assess efficacy on interior surfaces.
• The objective is to generate field data on performance and durability to support commercialization planning, partner discussions, and future scaling opportunities, moving from lab results to practical commercial applications.

Key Details

• Parties Involved: Biosenta Inc. (technology provider) and Livespace Homes (construction partner).
• Agreement Type: Field test and research agreement.
• Location: Alberta, Canada (specifically a multi-unit build).
• Scope of Test:
  • Nanoparticles will be incorporated into building materials and/or coatings.
  • Application is limited to two of the four units in a Livespace four-plex project.
  • Purpose is to enable side-by-side comparison to evaluate performance on selected interior surfaces and materials.
• Strategic Goals:
  • Confirm performance of nanoparticle technology in a real residential setting.
  • Generate field data on performance and durability.
  • Support commercialization planning, partner discussions, and future scaling opportunities.
• Technology Focus: Proprietary anti-microbial nanoparticle technology designed to protect surfaces from bacteria, mould, fungi, and other microbial growth.

Notable Quotes

• Am Gill, President and CEO, Biosenta: "People want homes that feel clean and safe. Our technology is designed to help protect surfaces from bacteria and mould, so families can worry less about what they cannot see."
• Gurpreet Gill, President, Livespace Homes: "We're always looking for practical innovations that can improve the performance and livability of the spaces we build. To our knowledge, this is a first-of-its-kind field test in a live multiunit build, allowing us to evaluate Biosenta's anti-microbial nanotechnology in real conditions and learn what it could mean for residential construction."